Malicious Activity Targeting COVID-19 Research, Vaccine Development

Original release date: July 16, 2020

In response to malicious activity targeting COVID-19 research and vaccine development in the United States, United Kingdom (UK), and Canada, the Cybersecurity and Infrastructure Security Agency (CISA), UK’s National Cyber Security Centre (NCSC), Canada’s Communications Security Establishment (CSE), and the National Security Agency (NSA) released a Joint Cybersecurity Advisory to expose the threat. A malicious cyber actor is using a variety of tools and techniques to target organizations involved in COVID-19 research and vaccine development. Tools include SOREFANG, WELLMESS, and WELLMAIL malware.
CISA encourages users and administrators to review the Joint Cybersecurity Advisory and the following Malware Analysis Reports for more information and to apply the mitigations provided.

This product is provided subject to this Notification and this Privacy & Use policy.